December 12, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Tuesday, December 11th 2012 at 07:16:00 PST stating that AspenBio Pharma Inc (NASDAQ:APPY) was expected to be Up After it crossed above its SqueezeTrigger Price of 2.13 on Tuesday, December 11th 2012. Click here to view the BUYINS.NET report:

http://www.buyins.net/releases/?sym=appy&id=334162

From August 2009 to November 2012, an aggregate amount of 54377324 shares of APPY have been shorted for a total dollar value of $108754648. The APPY SqueezeTrigger price of $2.13 is the volume weighted average price that all shorts are short in shares of APPY. There is still approximately $555,666 of potential short covering in shares of APPY.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

AspenBio Pharma Inc (NASDAQ:APPY) - AspenBio Pharma, Inc., a bio-pharmaceutical company, engages in the discovery, development, and commercialization of products that address un-met diagnostic and therapeutic needs. The Companys research and development activities primarily focus on a human appendicitis blood-based test and bovine single-chain recombinant reproduction enhancement drugs. Its lead product includes AppyScore, a blood-based diagnostic test that evaluates patients suspected of having acute appendicitis and diagnosing appendicitis in the hospital emergency department setting. The company also develops animal healthcare products focusing on reproduction, including BoviPure LH, a recombinant hormone analog for use with artificial insemination that induces ovulation and reduces the risk of pregnancy loss in dairy cows; BoviPure FSH, a single-chain bovine FSH analog for super-ovulation of cows; EquiPure LH, a single-chain LH analog for horses that stimulates follicular development, as well as induces ovulation in estrous mares; and EquiPure FSH, a single-chain FSH analog for horses that assists mares through transition and for super-ovulation. In addition, it manufactures and markets approximately 20-30 purified protein products primarily for use as controls by diagnostic test kit manufacturers and research facilities to determine whether diagnostic test kits are functioning properly. The company was founded in 2000 and is based in Castle Rock, Colorado..

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

N※N

AspenBio Pharma Inc (NASDAQ:APPY), Up By 5.53% ($0.12) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, December 11t